Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms of Response and Tolerance to Active RAS Inhibition in KRAS-Mutant Non–Small Cell Lung Cancer
Haniel A. Araújo, Ximo Pechuan-Jorge, Teng Zhou, et al.
Cancer Discovery (2024) Vol. 14, Iss. 11, pp. 2183-2208
Closed Access | Times Cited: 10

Showing 10 citing articles:

Lineage plasticity of the integrated stress response is a hallmark of cancer evolution.
Shiqi Diao, Jia Yi Zou, Shuo Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Unravelling lung adenocarcinoma with mucinous histology and its translational implications
S. Savic Prince, Obinna Chijioke, Lukas Bubendorf
Annals of Oncology (2025) Vol. 36, Iss. 3, pp. 235-237
Closed Access
Evaluation of molecular glue-induced neo-Protein-Protein Interaction with a cell lysate-based TR-FRET assay
Xiulei Mo, Yuhong Du, Haian Fu
(2025), pp. 100003-100003
Open Access
Reversible Small Molecule Multivariant Ras Inhibitors Display Tunable Affinity for the Active and Inactive Forms of Ras
Charles Parry, Francesca Pellicano, Alexander W. Schüttelkopf, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Breakthrough in RAS targeting with pan-RAS(ON) inhibitors RMC-7977 and RMC-6236
Panagiotis Filis, Dimitrios Salgkamis, Alexios Matikas, et al.
Drug Discovery Today (2024), pp. 104250-104250
Open Access | Times Cited: 2
First-line treatments for KRAS-mutant non-small cell lung cancer: current state and future perspectives
Qi He, Xiaoyan Liu, Liyan Jiang, et al.
Cancer Biology & Therapy (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 1
Advances and challenges in RAS signaling targeted therapy in leukemia
Yu Chen, Zhengfeng Yin, Kenneth D. Westover, et al.
Molecular Cancer Therapeutics (2024) Vol. 24, Iss. 1, pp. 33-46
Open Access | Times Cited: 1
The Far Side of Resistance to RAS Inhibitors
Michelangelo Marasco, Sandra Misale
Cancer Discovery (2024) Vol. 14, Iss. 11, pp. 2018-2020
Closed Access | Times Cited: 1
Investigating the role of KARS in lung adenocarcinoma via single-cell RNA sequencing
Huafang Hu, Yan Zhong, G Li, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
Opposing lineage specifiers induce a pro-tumor hybrid-identity state in lung adenocarcinoma
Gabriela Fort, Helen Arnold, Soledad A. Camolotto, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Mechanisms of Resistance to KRAS Inhibitors: Cancer Cells' Strategic Use of Normal Cellular Mechanisms to Adapt
Noritaka Tanaka, Hiromichi Ebi
Cancer Science (2024)
Open Access
Page 1

Scroll to top